Nifty
Sensex
:
:
11863.65
39482.17
35.40 (0.30%)
129.50 (0.33%)

Pharmaceuticals & Drugs

Rating :
62/99  (View)

BSE: 532482 | NSE: GRANULES

110.10
2.05 (1.90%)
21-May-2019 | 10:09AM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  107.60
  •  111.00
  •  107.60
  •  108.05
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  159494
  •  175.60
  •  123.40
  •  71.55

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,744.60
  • 11.61
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 3,607.41
  • 0.93%
  • 1.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.90%
  • 9.32%
  • 29.40%
  • FII
  • DII
  • Others
  • 3.01%
  • 0.00%
  • 15.37%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 19.27
  • 8.98
  • 7.47

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.59
  • 11.96
  • 0.18

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 39.26
  • 9.16
  • -2.26

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.87
  • 18.82
  • 18.18

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.53
  • 3.47
  • 2.78

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.57
  • 10.79
  • 10.71

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 19
Mar 18
Var%
Dec 18
Dec 17
Var%
Sep 18
Sep 17
Var%
Jun 18
Jun 17
Var%
Net Sales
613.32
503.82
21.73%
631.78
410.73
53.82%
580.87
392.56
47.97%
453.24
384.74
17.80%
Expenses
515.71
460.19
12.06%
518.48
336.70
53.99%
480.34
315.65
52.17%
380.64
308.74
23.29%
EBITDA
97.61
43.63
123.72%
113.30
74.03
53.05%
100.53
76.91
30.71%
72.60
76.00
-4.47%
EBIDTM
15.91%
8.66%
17.93%
18.02%
17.31%
19.59%
16.02%
19.75%
Other Income
1.88
9.67
-80.56%
5.88
0.86
583.72%
4.18
6.83
-38.80%
14.74
1.32
1,016.67%
Interest
6.85
6.21
10.31%
7.47
8.23
-9.23%
7.60
10.41
-26.99%
6.54
8.21
-20.34%
Depreciation
27.42
20.41
34.35%
27.01
19.60
37.81%
26.53
18.59
42.71%
24.53
17.60
39.38%
PBT
65.22
26.69
144.36%
84.69
47.06
79.96%
70.59
54.74
28.96%
56.27
51.51
9.24%
Tax
20.18
9.50
112.42%
26.46
16.90
56.57%
23.35
19.26
21.24%
19.11
17.73
7.78%
PAT
45.04
17.19
162.01%
58.23
30.16
93.07%
47.23
35.48
33.12%
37.16
33.78
10.01%
PATM
7.34%
3.41%
9.22%
7.34%
8.13%
9.04%
8.20%
8.78%
EPS
2.52
0.81
211.11%
2.37
1.38
71.74%
2.37
1.59
49.06%
2.04
1.61
26.71%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Net Sales
2,279.21
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
475.18
461.09
289.27
Net Sales Growth
34.72%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
37.63%
3.06%
59.40%
 
Cost Of Goods Sold
1,255.58
896.32
679.63
725.03
746.95
645.25
466.92
414.36
295.55
275.07
170.17
Gross Profit
1,023.63
788.30
730.93
632.15
545.97
450.61
297.45
239.60
179.63
186.02
119.11
GP Margin
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
37.80%
40.34%
41.18%
Total Expenditure
1,895.17
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
418.92
399.65
255.78
Power & Fuel Cost
-
48.22
38.67
34.97
45.73
36.70
37.71
26.28
23.07
18.61
9.42
% Of Sales
-
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
4.86%
4.04%
3.26%
Employee Cost
-
165.21
140.19
117.57
106.96
85.84
59.71
45.46
33.38
27.78
17.73
% Of Sales
-
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
7.02%
6.02%
6.13%
Manufacturing Exp.
-
123.40
88.60
66.97
50.89
38.68
24.34
18.90
14.71
30.79
19.63
% Of Sales
-
7.33%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
3.10%
6.68%
6.79%
General & Admin Exp.
-
80.48
67.65
60.38
59.84
44.42
26.96
21.31
16.52
18.01
12.14
% Of Sales
-
4.78%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
3.48%
3.91%
4.20%
Selling & Distn. Exp.
-
83.08
81.37
67.75
71.70
85.04
61.70
47.62
32.32
28.47
17.11
% Of Sales
-
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
6.80%
6.17%
5.91%
Miscellaneous Exp.
-
9.49
15.61
8.62
2.24
1.64
2.01
0.74
3.36
0.92
17.11
% Of Sales
-
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
0.71%
0.20%
3.31%
EBITDA
384.04
278.42
298.84
275.89
208.61
158.29
85.02
79.29
56.26
61.44
33.49
EBITDA Margin
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
11.84%
13.32%
11.58%
Other Income
26.68
10.84
9.93
5.62
4.34
4.31
2.06
1.38
0.80
12.28
1.00
Interest
28.46
33.06
32.26
37.07
32.35
20.43
17.67
16.99
11.99
17.55
15.68
Depreciation
105.49
76.20
71.51
58.40
52.65
29.81
23.08
20.70
18.31
18.57
11.80
PBT
276.77
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Tax
89.10
63.40
65.20
61.15
37.05
37.13
13.76
13.02
5.86
7.22
2.77
Tax Rate
32.19%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
21.90%
19.20%
39.46%
PAT
187.66
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
PAT before Minority Interest
187.66
116.60
139.79
124.89
90.91
75.23
32.57
29.95
20.90
30.37
4.25
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
4.40%
6.59%
1.47%
PAT Growth
60.93%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
43.30%
-31.18%
614.59%
 
Unadjusted EPS
9.30
5.49
7.52
5.95
4.46
3.72
16.21
14.93
10.42
15.14
2.12

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Shareholder's Funds
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
219.78
202.38
174.94
Share Capital
25.38
22.87
21.67
20.43
20.28
20.13
20.06
20.06
21.74
21.74
Total Reserves
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
199.72
180.64
153.20
Non-Current Liabilities
488.19
187.99
246.62
356.52
343.51
202.00
112.60
58.88
163.74
195.63
Secured Loans
433.13
123.90
183.66
302.59
295.86
174.85
87.30
37.08
135.85
166.05
Unsecured Loans
0.00
0.34
0.55
0.62
13.38
0.65
0.75
0.75
10.85
17.32
Long Term Provisions
7.70
7.25
5.58
4.03
3.97
2.04
1.53
1.19
0.00
0.00
Current Liabilities
844.57
787.13
654.75
415.03
292.54
205.78
213.63
157.11
49.26
34.20
Trade Payables
252.18
215.98
181.10
187.63
135.54
91.84
75.52
51.81
37.56
28.08
Other Current Liabilities
58.67
93.43
79.21
88.98
47.78
23.77
31.39
18.65
8.77
2.77
Short Term Borrowings
525.10
473.83
392.85
124.97
100.91
85.46
102.06
83.15
0.00
0.00
Short Term Provisions
8.62
3.90
1.58
13.45
8.30
4.71
4.66
3.50
2.93
3.35
Total Liabilities
2,636.94
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
435.77
415.38
404.77
Net Block
776.73
644.34
559.94
616.55
482.47
263.46
250.42
238.62
236.77
243.09
Gross Block
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
322.61
302.76
290.73
Accumulated Depreciation
422.90
339.32
263.05
227.21
171.43
123.95
104.07
83.99
65.99
47.64
Non Current Assets
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
256.75
239.52
245.41
Capital Work in Progress
514.52
267.43
76.56
62.03
124.56
108.80
29.30
6.85
2.45
2.02
Non Current Investment
156.56
108.23
70.11
0.19
0.19
0.19
0.19
0.30
0.30
0.29
Long Term Loans & Adv.
35.91
30.56
38.37
20.76
4.33
16.42
30.50
10.71
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
0.15
0.00
0.00
0.12
0.27
0.00
0.00
Current Assets
1,153.23
828.16
818.00
500.36
376.92
288.88
260.26
179.02
174.29
157.40
Current Investments
0.00
0.00
0.00
0.00
0.00
9.46
0.00
0.00
0.00
0.00
Inventories
279.95
269.18
253.72
224.52
174.16
136.48
109.91
75.13
68.63
59.51
Sundry Debtors
617.08
417.70
375.35
136.91
110.91
71.02
95.01
71.61
65.85
63.12
Cash & Bank
115.64
49.80
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84
Other Current Assets
140.57
39.83
9.97
71.58
50.10
30.21
23.36
20.29
26.32
21.93
Short Term Loans & Adv.
91.78
51.66
48.68
2.05
28.76
16.93
13.18
12.28
22.70
18.30
Net Current Assets
308.65
41.03
163.25
85.33
84.38
83.09
46.63
21.91
125.03
123.21
Total Assets
2,636.94
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31
435.77
415.38
404.77

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Cash From Operating Activity
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
48.56
59.73
-12.28
PBT
180.00
204.99
186.03
127.96
112.36
46.32
42.98
26.76
37.60
7.02
Adjustment
107.45
95.14
92.63
85.37
50.39
41.46
37.74
33.11
24.93
24.16
Changes in Working Capital
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
-5.70
3.46
-42.83
Cash after chg. in Working capital
57.42
247.77
198.97
182.00
131.73
102.39
37.11
54.16
65.99
-11.65
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
-5.60
-6.26
-0.63
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
-25.09
-13.36
-8.83
Net Fixed Assets
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
-23.22
-10.88
-2.27
Net Investments
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
0.00
-0.93
0.00
Others
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
-1.87
-1.55
-6.56
Cash from Financing Activity
528.62
55.87
85.67
18.83
146.72
46.33
48.86
-24.96
-45.73
23.10
Net Cash Inflow / Outflow
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
-1.49
0.64
1.99
Opening Cash & Equivalents
42.37
124.35
54.85
41.75
41.71
31.98
11.99
13.47
12.84
10.85
Closing Cash & Equivalent
108.03
42.37
130.29
65.31
41.75
41.71
31.98
11.99
13.47
12.84

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Mar 11
Mar 10
Mar 09
Book Value (Rs.)
51.17
39.40
29.20
20.98
17.36
13.40
12.19
10.96
9.93
8.54
ROA
5.16%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
4.91%
7.41%
1.09%
ROE
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
9.98%
16.40%
2.49%
ROCE
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
11.00%
15.67%
6.75%
Fixed Asset Turnover
1.55
1.59
1.66
1.77
2.14
2.11
1.96
1.54
1.58
1.21
Receivable days
111.62
100.84
67.60
33.47
29.73
38.66
45.82
52.00
50.21
62.22
Inventory Days
59.23
66.49
63.11
54.79
50.77
57.37
50.89
54.38
49.89
69.48
Payable days
59.44
64.87
59.99
53.57
43.67
44.19
40.05
38.81
29.80
38.79
Cash Conversion Cycle
111.41
102.46
70.72
34.69
36.83
51.84
56.66
67.57
70.30
92.90
Total Debt/Equity
0.75
0.73
1.01
1.14
1.25
1.00
0.83
0.63
0.73
1.06
Interest Cover
6.44
7.36
6.02
4.96
6.50
3.62
3.53
3.23
3.14
1.45

News Update


  • Granules India - Quarterly Results
    9th May 2019, 15:09 PM

    Read More
  • Granules India gets USFDA’s approval for Acetaminophen Extended Release Tablets
    18th Apr 2019, 09:11 AM

    Acetaminophen 650 mg extended release tablets are used primarily for temporary pain management including arthritis relief

    Read More
  • Granules India’s Promoters dispose stake to mobilize Rs 50 crore
    8th Mar 2019, 11:17 AM

    The promoters are also monetizing personal assets worth up to another Rs 50 crore

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.